While the terms of the Trans-Pacific Partnership (TPP) were kept secret from the public and policymakers during negotiations, US negotiators relied heavily on input from the corporate insiders who populate the US government-appointed Industry Trade Advisory Committees.
[Seed industry lobby group] BIO spent roughly $8 million on lobbying each year while the TPP was under negotiation, paying firms like Akin Gump Strauss Hauer & Feld $80,000 annually to lobby for patent provision in the Trans-Pacific Partnership trade negotiations.
The results of this lobbying blitz were unknown until the final text of the agreement was released in November of last year… Experts have called the TPP a ‘big win’ for the biotech seed industry, and many warn that the trade deal will further enrich seed companies at the expense of farmers’ rights.
[The Trans-Pacific Partnership] effectively outlaws the saving of seeds from one season to the next, a practice the majority of the world’s farmers rely upon. Farmers are prohibited from saving, replanting, and exchanging protected seed, and breeders* are granted exclusive right to germplasm**.
– Exerpted and adapted from The Trans Pacific Partnership will hurt farmers and make seed companies richer by Alex Press, in The Nation, June 10, 2016.
* In this context, “breeders” means large-scale corporations or other institutions that carry out plant breeding to develop new crop varieties. It excludes small-scale farmers, or local seed sellers or coops, who don’t have the money to pay for lawyers to register and apply for patents for their seeds, or the time, money and extra land that would be required to carry out the seed trials that would be required for the patent application to even be considered.
** “Gerplasm” technically means the DNA or genetic material of a particular plant crop; practically it means seeds.